Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
61,540,743
-
Share change
-
+452,067
-
Total reported value
-
$236,207,732
-
Put/Call ratio
-
174%
-
Price per share
-
$3.84
-
Number of holders
-
98
-
Value change
-
-$4,805,094
-
Number of buys
-
65
-
Number of sells
-
32
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q2 2019
As of 30 Jun 2019,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,540,743 shares.
The largest 10 holders included
Consonance Capital Management LP, BlackRock Inc., ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MANGROVE PARTNERS, Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, MORGAN STANLEY, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.